関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Glycine | HCID 750 | — |
| 反応物 | D-Phenylalanine | HCID 71567 | — |
| 反応物 | N-Methyl-L-valine | HCID 444080 | — |
| 反応物 | 4-tert-Butyl hydrogen L-aspartate | HCID 7010570 | — |
| 反応物 | Trifluoroacetic acid methylene chloride | HCID 21863450 | — |
| 反応物 | HCID 178491778 | HCID 178491778 | — |
| 反応物 | HCID 178491779 | HCID 178491779 | — |
| 生成物 | HCID 178491777 | HCID 178491777 | — |
反応手順
Fmoc-Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-ONa (SEQ ID NO 41) is synthesized using solid-phase Merrifield-type procedures by sequentially adding NMeVal, DPhe, Asp(OBut), Gly and Fmoc-Arg(Mtr) in a step-wise manner to a 4-hydroxymethyl-phenoxymethyl-polystyrene resin (Wang type resin) (customary Merrifield-type methods of peptide synthesis are applied as described in Houben-Weyl, l.c., Volume 15/II, Pages 1 to 806 (1974). The polystyrene resin and amino acid residues precursors are commercially available from Aldrich, Sigma or Fluka chemical companies). After completion of sequential addition of the amino acid residues, the resin is then eliminated from the peptide chain using a 1:1 mixture of TFA/dichloromethane which provides the Fmoc-Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-OH product (SEQ ID NO 42). The Fmoc group is then removed with a 1:1 mixture of piperidine/DMF which provides the crude Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-OH (SEQ ID NO 43) precursor which is then purified by HPLC in the customary manner.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07053041B1 |
|---|
| 出典データセット | uspto-grants-2006_05 |
|---|
| ORD ID | ord-8a1f3e9205a64558bb261b5185b2c6ca |
|---|
| 出典メモ | uspto-grants-2006_05 |
|---|